<SEC-DOCUMENT>0001047469-17-005313-index.html : 20170818 <SEC-HEADER>0001047469-17-005313.hdr.sgml : 20170818 <ACCEPTANCE-DATETIME>20170818161823 ACCESSION NUMBER: 0001047469-17-005313 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20170915 FILED AS OF DATE: 20170818 DATE AS OF CHANGE: 20170818 EFFECTIVENESS DATE: 20170818 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 171041309 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>a2233043zdef14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: a2233043zdef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g312275.jpg <DESCRIPTION>G312275.JPG <TEXT> Document 2 - file: g312275.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g761950.jpg <DESCRIPTION>G761950.JPG <TEXT> Document 3 - file: g761950.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g200434bei001.gif <DESCRIPTION>G200434BEI001.GIF <TEXT> Document 4 - file: g200434bei001.gif
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g200434bei002.gif <DESCRIPTION>G200434BEI002.GIF <TEXT> Document 5 - file: g200434bei002.gif
</DOCUMENT> </SEC-DOCUMENT>